Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cornelia M. van Duijn is active.

Publication


Featured researches published by Cornelia M. van Duijn.


Atherosclerosis | 2010

Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: Results of genome-wide association analyses including 4659 European individuals

Iris M. Heid; Peter Henneman; Andrew A. Hicks; Stefan Coassin; Thomas W. Winkler; Yurii S. Aulchenko; Christian Fuchsberger; Kijoung Song; Marie-France Hivert; Dawn M. Waterworth; Nicholas J. Timpson; J. Brent Richards; John Perry; Toshiko Tanaka; Najaf Amin; Barbara Kollerits; Irene Pichler; Ben A. Oostra; Barbara Thorand; Rune R. Frants; Thomas Illig; Josée Dupuis; Beate Glaser; Tim D. Spector; Jack M. Guralnik; Josephine M. Egan; Jose C. Florez; David Evans; Nicole Soranzo; Stefania Bandinelli

OBJECTIVEnPlasma adiponectin is strongly associated with various components of metabolic syndrome, type 2 diabetes and cardiovascular outcomes. Concentrations are highly heritable and differ between men and women. We therefore aimed to investigate the genetics of plasma adiponectin in men and women.nnnMETHODSnWe combined genome-wide association scans of three population-based studies including 4659 persons. For the replication stage in 13795 subjects, we selected the 20 top signals of the combined analysis, as well as the 10 top signals with p-values less than 1.0 x 10(-4) for each the men- and the women-specific analyses. We further selected 73 SNPs that were consistently associated with metabolic syndrome parameters in previous genome-wide association studies to check for their association with plasma adiponectin.nnnRESULTSnThe ADIPOQ locus showed genome-wide significant p-values in the combined (p=4.3 x 10(-24)) as well as in both women- and men-specific analyses (p=8.7 x 10(-17) and p=2.5 x 10(-11), respectively). None of the other 39 top signal SNPs showed evidence for association in the replication analysis. None of 73 SNPs from metabolic syndrome loci exhibited association with plasma adiponectin (p>0.01).nnnCONCLUSIONSnWe demonstrated the ADIPOQ gene as the only major gene for plasma adiponectin, which explains 6.7% of the phenotypic variance. We further found that neither this gene nor any of the metabolic syndrome loci explained the sex differences observed for plasma adiponectin. Larger studies are needed to identify more moderate genetic determinants of plasma adiponectin.


Proceedings of the National Academy of Sciences of the United States of America | 2014

Common genetic variants associated with cognitive performance identified using the proxy-phenotype method

Cornelius A. Rietveld; Tonu Esko; Gail Davies; Tune H. Pers; Patrick Turley; Beben Benyamin; Christopher F. Chabris; Valur Emilsson; Andrew D. Johnson; James J. Lee; Christiaan de Leeuw; Riccardo E. Marioni; Sarah E. Medland; Michael B. Miller; Olga Rostapshova; Sven J. van der Lee; Anna A. E. Vinkhuyzen; Najaf Amin; Dalton Conley; Jaime Derringer; Cornelia M. van Duijn; Rudolf S. N. Fehrmann; Lude Franke; Edward L. Glaeser; Narelle K. Hansell; Caroline Hayward; William G. Iacono; Carla A. Ibrahim-Verbaas; Vincent W. V. Jaddoe; Juha Karjalainen

Significance We identify several common genetic variants associated with cognitive performance using a two-stage approach: we conduct a genome-wide association study of educational attainment to generate a set of candidates, and then we estimate the association of these variants with cognitive performance. In older Americans, we find that these variants are jointly associated with cognitive health. Bioinformatics analyses implicate a set of genes that is associated with a particular neurotransmitter pathway involved in synaptic plasticity, the main cellular mechanism for learning and memory. In addition to the substantive contribution, this work also serves to show a proxy-phenotype approach to discovering common genetic variants that is likely to be useful for many phenotypes of interest to social scientists (such as personality traits). We identify common genetic variants associated with cognitive performance using a two-stage approach, which we call the proxy-phenotype method. First, we conduct a genome-wide association study of educational attainment in a large sample (n = 106,736), which produces a set of 69 education-associated SNPs. Second, using independent samples (n = 24,189), we measure the association of these education-associated SNPs with cognitive performance. Three SNPs (rs1487441, rs7923609, and rs2721173) are significantly associated with cognitive performance after correction for multiple hypothesis testing. In an independent sample of older Americans (n = 8,652), we also show that a polygenic score derived from the education-associated SNPs is associated with memory and absence of dementia. Convergent evidence from a set of bioinformatics analyses implicates four specific genes (KNCMA1, NRXN1, POU2F3, and SCRT). All of these genes are associated with a particular neurotransmitter pathway involved in synaptic plasticity, the main cellular mechanism for learning and memory.


Journal of The American Society of Nephrology | 2010

Common Genetic Variants Associate with Serum Phosphorus Concentration

Bryan Kestenbaum; Nicole L. Glazer; Anna Köttgen; Janine F. Felix; Shih Jen Hwang; Yongmei Liu; Kurt Lohman; Stephen B. Kritchevsky; Dorothy B. Hausman; Ann Kristin Petersen; Christian Gieger; Janina S. Ried; Thomas Meitinger; Tim M. Strom; H.-Erich Wichmann; Harry Campbell; Caroline Hayward; Igor Rudan; Ian H. de Boer; Bruce M. Psaty; Kenneth Rice; Yii-Der I. Chen; Man Li; Dan E. Arking; Eric Boerwinkle; Josef Coresh; Qiong Yang; Daniel Levy; Frank J. A. van Rooij; Abbas Dehghan

Phosphorus is an essential mineral that maintains cellular energy and mineralizes the skeleton. Because complex actions of ion transporters and regulatory hormones regulate serum phosphorus concentrations, genetic variation may determine interindividual variation in phosphorus metabolism. Here, we report a comprehensive genome-wide association study of serum phosphorus concentration. We evaluated 16,264 participants of European ancestry from the Cardiovascular Heath Study, Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and the Rotterdam Study. We excluded participants with an estimated GFR <45 ml/min per 1.73 m(2) to focus on phosphorus metabolism under normal conditions. We imputed genotypes to approximately 2.5 million single-nucleotide polymorphisms in the HapMap and combined study-specific findings using meta-analysis. We tested top polymorphisms from discovery cohorts in a 5444-person replication sample. Polymorphisms in seven loci with minor allele frequencies 0.08 to 0.49 associate with serum phosphorus concentration (P = 3.5 x 10(-16) to 3.6 x 10(-7)). Three loci were near genes encoding the kidney-specific type IIa sodium phosphate co-transporter (SLC34A1), the calcium-sensing receptor (CASR), and fibroblast growth factor 23 (FGF23), proteins that contribute to phosphorus metabolism. We also identified genes encoding phosphatases, kinases, and phosphodiesterases that have yet-undetermined roles in phosphorus homeostasis. In the replication sample, five of seven top polymorphisms associate with serum phosphorous concentrations (P < 0.05 for each). In conclusion, common genetic variants associate with serum phosphorus in the general population. Further study of the loci identified in this study may help elucidate mechanisms of phosphorus regulation.


American Journal of Epidemiology | 2013

Association of Adiposity Genetic Variants With Menarche Timing in 92,105 Women of European Descent

Lindsay Fernández-Rhodes; Ellen W. Demerath; Diana L. Cousminer; Ran Tao; Jill Dreyfus; Tonu Esko; Albert V. Smith; Vilmundur Gudnason; Tamara B. Harris; Lenore Launer; Patrick F. McArdle; Laura M. Yerges-Armstrong; Cathy E. Elks; David P. Strachan; Zoltán Kutalik; Peter Vollenweider; Bjarke Feenstra; Heather A. Boyd; Andres Metspalu; Evelin Mihailov; Linda Broer; M. Carola Zillikens; Ben A. Oostra; Cornelia M. van Duijn; Kathryn L. Lunetta; John R B Perry; Anna Murray; Daniel L. Koller; Dongbing Lai; Tanguy Corre

Obesity is of global health concern. There are well-described inverse relationships between female pubertal timing and obesity. Recent genome-wide association studies of age at menarche identified several obesity-related variants. Using data from the ReproGen Consortium, we employed meta-analytical techniques to estimate the associations of 95 a priori and recently identified obesity-related (body mass index (weight (kg)/height (m)(2)), waist circumference, and waist:hip ratio) single-nucleotide polymorphisms (SNPs) with age at menarche in 92,116 women of European descent from 38 studies (1970-2010), in order to estimate associations between genetic variants associated with central or overall adiposity and pubertal timing in girls. Investigators in each study performed a separate analysis of associations between the selected SNPs and age at menarche (ages 9-17 years) using linear regression models and adjusting for birth year, site (as appropriate), and population stratification. Heterogeneity of effect-measure estimates was investigated using meta-regression. Six novel associations of body mass index loci with age at menarche were identified, and 11 adiposity loci previously reported to be associated with age at menarche were confirmed, but none of the central adiposity variants individually showed significant associations. These findings suggest complex genetic relationships between menarche and overall obesity, and to a lesser extent central obesity, in normal processes of growth and development.


Circulation-cardiovascular Genetics | 2016

Rare Exome Sequence Variants in CLCN6 Reduce Blood Pressure Levels and Hypertension Risk

Bing Yu; Sara L. Pulit; Shih Jen Hwang; Jennifer A. Brody; Najaf Amin; Paul L. Auer; Joshua C. Bis; Eric Boerwinkle; Gregory L. Burke; Aravinda Chakravarti; Adolfo Correa; Albert W. Dreisbach; Oscar H. Franco; Georg Ehret; Nora Franceschini; Albert Hofman; D. Y. Lin; Ginger A. Metcalf; Solomon K. Musani; Donna M. Muzny; Walter Palmas; Leslie J. Raffel; Alex P. Reiner; Ken Rice; Jerome I. Rotter; Narayanan Veeraraghavan; Ervin R. Fox; Xiuqing Guo; Kari E. North; Richard A. Gibbs

Background—Rare genetic variants influence blood pressure (BP). Methods and Results—Whole-exome sequencing was performed on DNA samples from 17 956 individuals of European ancestry and African ancestry (14 497, first-stage discovery and 3459, second-stage discovery) to examine the effect of rare variants on hypertension and 4 BP traits: systolic BP, diastolic BP, pulse pressure, and mean arterial pressure. Tests of ≈170 000 common variants (minor allele frequency, ≥1%; statistical significance, P⩽2.9×10−7) and gene-based tests of rare variants (minor allele frequency, <1%; ≈17 000 genes; statistical significance, P⩽1.5×10−6) were evaluated for each trait and ancestry, followed by multiethnic meta-analyses. In the first-stage discovery, rare coding variants (splicing, stop-gain, stop-loss, nonsynonymous variants, or indels) in CLCN6 were associated with lower diastolic BP (cumulative minor allele frequency, 1.3%; &bgr;=−3.20; P=4.1×10−6) and were independent of a nearby common variant (rs17367504) previously associated with BP. CLCN6 rare variants were also associated with lower systolic BP (&bgr;=−4.11; P=2.8×10−4), mean arterial pressure (&bgr;=−3.50; P=8.9×10−6), and reduced hypertension risk (odds ratio, 0.72; P=0.017). Meta-analysis of the 2-stage discovery samples showed that CLCN6 was associated with lower diastolic BP at exome-wide significance (cumulative minor allele frequency, 1.1%; &bgr;=−3.30; P=5.0×10−7). Conclusions—These findings implicate the effect of rare coding variants in CLCN6 in BP variation and offer new insights into BP regulation.


Journal of Alzheimer's Disease | 2011

Association of HSP70 and its co-chaperones with Alzheimer's disease

Linda Broer; Mohammad Arfan Ikram; Maaike Schuur; Anita L. DeStefano; Joshua C. Bis; Fan Liu; Fernando Rivadeneira; André G. Uitterlinden; Alexa Beiser; William T. Longstreth; Albert Hofman; Yurii S. Aulchenko; Sudha Seshadri; Annette L. Fitzpatrick; Ben A. Oostra; Monique M.B. Breteler; Cornelia M. van Duijn

The heat shock protein (HSP) 70 family has been implicated in the pathology of Alzheimers disease (AD). In this study, we examined common genetic variations in the 80 genes encoding HSP70 and its co-chaperones. We conducted a study in a series of 462 patients and 5238 unaffected participants derived from the Rotterdam Study, a population-based study including 7983 persons aged 55 years and older. We genotyped a total of 12,053 Single Nucleotide Polymorphisms (SNPs) using the HumanHap550K Genotyping BeadChip from Illumina. Replication was performed in two independent cohort studies, the Framingham Heart study (FHS; n = 806) and Cardiovascular Health Study (CHS; n = 2150). When adjusting for multiple testing, we found a small but consistent, though not significant effect of rs12118313 located 32 kb from PFDN2, with an OR of 1.19 (p-value from meta-analysis = 0.003). However this SNP was in the intron of another gene, suggesting it is unlikely this SNP reflects the effect of PFDN2. In a formal pathway analysis we found nominally significant evidence for an association of BAG, DNAJA and prefoldin with AD. These findings corroborate with those of a study of 2032 AD patients and 5328 controls, in which several members of the prefoldin family showed evidence for association to AD. Our study did not reveal evidence for a genetic variant if the HSP70 family with a major effect on AD. However, our findings of the single SNP analysis and pathway analysis suggest that multiple genetic variants in prefoldin are associated with AD.


Circulation-cardiovascular Genetics | 2016

Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis

Pradeep Natarajan; Joshua C. Bis; Lawrence F. Bielak; Amanda J. Cox; Marcus Dörr; Mary F. Feitosa; Nora Franceschini; Xiuqing Guo; Shih Jen Hwang; Aaron Isaacs; Min A. Jhun; Maryam Kavousi; Ruifang Li-Gao; Leo-Pekka Lyytikäinen; Riccardo E. Marioni; Ulf Schminke; Nathan O. Stitziel; Hayato Tada; Jessica van Setten; Albert V. Smith; Dina Vojinovic; Lisa R. Yanek; Jie Yao; Laura M. Yerges-Armstrong; Najaf Amin; Usman Baber; Ingrid B. Borecki; J. Jeffrey Carr; Yii-Der Ida Chen; L. Adrienne Cupples

Background—The burden of subclinical atherosclerosis in asymptomatic individuals is heritable and associated with elevated risk of developing clinical coronary heart disease. We sought to identify genetic variants in protein-coding regions associated with subclinical atherosclerosis and the risk of subsequent coronary heart disease. Methods and Results—We studied a total of 25u2009109 European ancestry and African ancestry participants with coronary artery calcification (CAC) measured by cardiac computed tomography and 52u2009869 participants with common carotid intima–media thickness measured by ultrasonography within the CHARGE Consortium (Cohorts for Heart and Aging Research in Genomic Epidemiology). Participants were genotyped for 247u2009870 DNA sequence variants (231u2009539 in exons) across the genome. A meta-analysis of exome-wide association studies was performed across cohorts for CAC and carotid intima–media thickness. APOB p.Arg3527Gln was associated with 4-fold excess CAC (P=3×10−10). The APOE &egr;2 allele (p.Arg176Cys) was associated with both 22.3% reduced CAC (P=1×10−12) and 1.4% reduced carotid intima–media thickness (P=4×10−14) in carriers compared with noncarriers. In secondary analyses conditioning on low-density lipoprotein cholesterol concentration, the &egr;2 protective association with CAC, although attenuated, remained strongly significant. Additionally, the presence of &egr;2 was associated with reduced risk for coronary heart disease (odds ratio 0.77; P=1×10−11). Conclusions—Exome-wide association meta-analysis demonstrates that protein-coding variants in APOB and APOE associate with subclinical atherosclerosis. APOE &egr;2 represents the first significant association for multiple subclinical atherosclerosis traits across multiple ethnicities, as well as clinical coronary heart disease.


European Journal of Epidemiology | 2014

Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants

Linda Broer; Julia Raschenberger; Joris Deelen; Massimo Mangino; Veryan Codd; Kirsi H. Pietiläinen; Eva Albrecht; Najaf Amin; Marian Beekman; Anton J. M. de Craen; Christian Gieger; Margot Haun; Peter Henneman; Christian Herder; Iiris Hovatta; Annika Laser; Lyudmyla Kedenko; Wolfgang Koenig; Barbara Kollerits; Eeva Moilanen; Ben A. Oostra; Bernhard Paulweber; Lydia Quaye; Aila Rissanen; Michael Roden; Ida Surakka; Ana M. Valdes; Katriina Vuolteenaho; Barbara Thorand; Ko Willems van Dijk

AbstractnOxidative stress and inflammation are major contributors to accelerated age-related relative telomere length (RTL) shortening. Both conditions are strongly linked to leptin and adiponectin, the most prominent adipocyte-derived protein hormones. As high leptin levels and low levels of adiponectin have been implicated in inflammation, one expects adiponectin to be positively associated with RTL while leptin should be negatively associated. Within the ENGAGE consortium, we investigated the association of RTL with adiponectin and leptin in seven independent cohorts with a total of 11,448 participants. We performed partial correlation analysis on Z-transformed RTL and LN-transformed leptin/adiponectin, adjusting for age and sex. In extended models we adjusted for body mass index (BMI) and C-reactive protein (CRP). Adiponectin showed a borderline significant association with RTL. This appeared to be determined by a single study and when the outlier study was removed, this association disappeared. The association between RTL and leptin was highly significant (rxa0=xa0−0.05; pxa0=xa01.81xa0×xa010−7). Additional adjustment for BMI or CRP did not change the results. Sex-stratified analysis revealed no difference between men and women. Our study suggests that high leptin levels are associated with short RTL.


Multiple Sclerosis Journal – Experimental, Translational and Clinical | 2016

Burden of genetic risk variants in multiple sclerosis families in the Netherlands

Julia Y. Mescheriakova; Linda Broer; Simin Wahedi; Andre Uitterlinden; Cornelia M. van Duijn; Rogier Q. Hintzen

Background Approximately 20% of multiple sclerosis patients have a family history of multiple sclerosis. Studies of multiple sclerosis aggregation in families are inconclusive. Objective To investigate the genetic burden based on currently discovered genetic variants for multiple sclerosis risk in patients from Dutch multiple sclerosis multiplex families versus sporadic multiple sclerosis cases, and to study its influence on clinical phenotype and disease prediction. Methods Our study population consisted of 283 sporadic multiple sclerosis cases, 169 probands from multiplex families and 2028 controls. A weighted genetic risk score based on 102 non-human leukocyte antigen loci and HLA-DRB1*1501 was calculated. Results The weighted genetic risk score based on all loci was significantly higher in familial than in sporadic cases. The HLA-DRB1*1501 contributed significantly to the difference in genetic burden between the groups. A high weighted genetic risk score was significantly associated with a low age of disease onset in all multiple sclerosis patients, but not in the familial cases separately. The genetic risk score was significantly but modestly better in discriminating familial versus sporadic multiple sclerosis from controls. Conclusion Familial multiple sclerosis patients are more loaded with the common genetic variants than sporadic cases. The difference is mainly driven by HLA-DRB1*1501. The predictive capacity of genetic loci is poor and unlikely to be useful in clinical settings.


European Journal of Human Genetics | 2015

Genome-wide association analysis on five isolated populations identifies variants of the HLA-DOA gene associated with white wine liking

Nicola Pirastu; Maarten Kooyman; Michela Traglia; Antonietta Robino; Sara M. Willems; Giorgio Pistis; Najaf Amin; Cinzia Sala; Lennart C. Karssen; Cornelia M. van Duijn; Daniela Toniolo; Paolo Gasparini

Wine is the most popular alcoholic beverage around the world and because of its importance in society has been widely studied. Understanding what drives its flavor has been a quest for decades but much is still unknown and will be determined at least in part by individual taste preferences. Recently studies in the genetics of taste have uncovered the role of different genes in the determination of food preferences giving new insight on its physiology. In this context we have performed a genome-wide association study on red and white wine liking using three isolated populations collected in Italy, and replicated our results on two additional populations coming from the Netherland and Central Asia for a total of 3885 samples. We have found a significant association (P=2.1 × 10−8) between white wine liking and rs9276975:C>T a polymorphism in the HLA-DOA gene encoding a non-canonical MHC II molecule, which regulates other MHC II molecules. The same association was also found with red wine liking (P=8.3 × 10−6). Sex-separated analysis have also revealed that the effect of HLA-DOA is twice as large in women as compared to men suggesting an interaction between this polymorphism and gender. Our results are one of the first examples of genome-wide association between liking of a commonly consumed food and gene variants. Moreover, our results suggest a role of the MHC system in the determination of food preferences opening new insight in this field in general.

Collaboration


Dive into the Cornelia M. van Duijn's collaboration.

Top Co-Authors

Avatar

Ben A. Oostra

Erasmus University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Albert Hofman

Battelle Memorial Institute

View shared research outputs
Top Co-Authors

Avatar

Yurii S. Aulchenko

Novosibirsk State University

View shared research outputs
Top Co-Authors

Avatar

Najaf Amin

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linda Broer

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Bruce M. Psaty

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Eric Boerwinkle

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Andre Uitterlinden

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Abbas Dehghan

Erasmus University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge